Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013
What this trial is testing
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Who this might be right for
Acinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more
National Cancer Institute (NCI) 818